Physician profile
Jonathan A Hammond
NPI 1235115965
$9,378.13
in general payments reported to CMS, 2019-2025
10 companies · $209 in 2025
The $209 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,197 · 2020: $24.37 · 2021: $6,153 · 2022: $361 · 2023: $544 · 2024: $890 · 2025: $209.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239 · Travel and Lodging: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,239.32 |
| Travel and Lodging | $403.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,486.70 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| Atricure, INC. | $1,488.89 | 2019-2024 | |
| Abiomed | $557.54 | 2019-2022 | |
| Edwards Lifesciences Corporation | $281.56 | 2019-2023 | |
| W. L. Gore & Associates, INC. | $195.09 | 2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Artivion, INC. | $148.03 | 2023 | On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Astrazeneca Pharmaceuticals LP | $111.97 | 2021 | |
| Endologix LLC | $47.64 | 2024 | Afx2 Bifurcated Endograft System |
| Lemaitre Vascular, INC. | $36.34 | 2024-2025 | Pruitt Irrigation Occlusion Catheter, Restoreflow |
| Boston Scientific Corporation | $24.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Hammond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.